Page last updated: 2024-10-31

metoclopramide and Soft Tissue Neoplasms

metoclopramide has been researched along with Soft Tissue Neoplasms in 1 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Soft Tissue Neoplasms: Neoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Toma, S1
Coialbu, T1
Biassoni, L1
Folco, U1
Gatti, C1
Canavese, G1
Giacchero, A1
Rosso, R1

Trials

1 trial available for metoclopramide and Soft Tissue Neoplasms

ArticleYear
Epidoxorubicin plus ifosfamide in advanced and/or metastatic soft-tissue sarcomas.
    Cancer chemotherapy and pharmacology, 1990, Volume: 26, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship,

1990